A study led by UC Irvine oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group found postmenopausal women with the most common type of metastatic breast cancer can now live longer with a new treatment option. The findings appear in the Aug. 2 issue of the iNew England Journal of Medicine/i. A combination of the two anti-estrogen drugs anastrozole and fulvestrant extended the median survival time of women with Stage 4 hormone receptor-positive ...Thursday, 2 August 2012
Drug Combo Helps Women With Common Metastatic Breast Cancer Live Longer
A study led by UC Irvine oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group found postmenopausal women with the most common type of metastatic breast cancer can now live longer with a new treatment option. The findings appear in the Aug. 2 issue of the iNew England Journal of Medicine/i. A combination of the two anti-estrogen drugs anastrozole and fulvestrant extended the median survival time of women with Stage 4 hormone receptor-positive ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment